Literature DB >> 16822885

Granulocyte colony-stimulating factor mobilizes more dendritic cell subsets than granulocyte-macrophage colony-stimulating factor with no polarization of dendritic cell subsets in normal donors.

Paul J Shaughnessy1, Carlos Bachier, Charles F Lemaistre, Cagla Akay, Brad H Pollock, Yair Gazitt.   

Abstract

Dendritic cells (DCs) are effective antigen-presenting cells. We hypothesized that increasing the DC populations in donor lymphocyte infusions (DLIs) may augment the graft versus malignancy effect, particularly if granulocyte-macrophage colony-stimulating factor (GM-CSF) mobilization resulted in increased precursor dendritic cell (pDC) 1 cells. Mature DCs, pDC1 cells, pDC2 cells, and CD34(+) cells from the same donor were compared after granulocyte colony-stimulating factor (G-CSF) mobilized peripheral blood stem cell collections and GM-CSF mobilized DLI collections. Mobilization with G-CSF resulted in up to a 10-fold larger number of CD34(+) cells per kg and a 3-5-fold larger number of mature DCs, pDC1 cells, and pDC2 cells within the same donor compared with GM-CSF. The ratio of pDC1 to pDC2 in each donor remained constant with either cytokine. In this small sample of normal donors, it appears that G-CSF mobilizes more CD34(+) cells, mature DCs, pDC1 cells, and pDC2 cells within the same donor than does GM-CSF, with no significant polarization by G-CSF or GM-CSF for either pDC1 or pDC2 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822885     DOI: 10.1634/stemcells.2005-0492

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  5 in total

1.  Successful granulocyte-colony stimulating factor treatment of Crohn's disease is associated with the appearance of circulating interleukin-10-producing T cells and increased lamina propria plasmacytoid dendritic cells.

Authors:  P J Mannon; F Leon; I J Fuss; B A Walter; M Begnami; M Quezado; Z Yang; C Yi; C Groden; J Friend; R L Hornung; M Brown; S Gurprasad; B Kelsall; W Strober
Journal:  Clin Exp Immunol       Date:  2008-12-15       Impact factor: 4.330

2.  A randomized study comparing chemotherapy followed by G-CSF alone or in combination with GM-CSF for mobilization of peripheral blood stem cells in patients with non-Hodgkin's lymphomas.

Authors:  Chitra Hosing; Mark F Munsell; James M Reuben; Uday Popat; Bang-Ning Lee; Hui Gao; Martin Körbling; Elizabeth J Shpall; Partow Kebriaei; Amin Alousi; Marcos De Lima; John McMannis; Muzaffar Qazilbash; Paolo Anderlini; Sergio Giralt; Richard E Champlin; Issa Khouri
Journal:  J Blood Med       Date:  2010-04-14

3.  Case Report: In Situ Vaccination by Autologous CD16+ Dendritic Cells and Anti-PD-L 1 Antibody Synergized With Radiotherapy To Boost T Cells-Mediated Antitumor Efficacy In A Psoriatic Patient With Cutaneous Squamous Cell Carcinoma.

Authors:  Jun-Wei Huang; Chun-Lin Kuo; Li-Tzu Wang; Kevin Sheng-Kai Ma; Wen-Yen Huang; Feng-Cheng Liu; Kuender D Yang; Bing-Heng Yang
Journal:  Front Immunol       Date:  2021-12-23       Impact factor: 7.561

4.  In Vivo Administration of Recombinant Human Granulocyte Colony-Stimulating Factor Increases the Immune Effectiveness of Dendritic Cell-Based Cancer Vaccination.

Authors:  Shigetaka Shimodaira; Ryu Yanagisawa; Terutsugu Koya; Koichi Hirabayashi; Yumiko Higuchi; Takuya Sakamoto; Misa Togi; Tomohisa Kato; Takashi Kobayashi; Tomonobu Koizumi; Shigeo Koido; Haruo Sugiyama
Journal:  Vaccines (Basel)       Date:  2019-09-19

5.  Sepsis Inflammation Impairs the Generation of Functional Dendritic Cells by Targeting Their Progenitors.

Authors:  Jie Lu; Kun Sun; Huiping Yang; Dan Fan; He Huang; Yi Hong; Shuiyan Wu; HuiTing Zhou; Fang Fang; YanHong Li; Lijun Meng; Jie Huang; Zhenjiang Bai
Journal:  Front Immunol       Date:  2021-09-09       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.